Milk protein may shield preemie lungs from ventilator infection
NCT ID NCT07255742
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether giving lactoferrin, a protein found in milk, to preterm babies on breathing machines could prevent ventilator-associated pneumonia (VAP). Fifty premature newborns received either lactoferrin plus standard care or standard care alone. The goal was to see if the supplement reduced infections, shortened time on the ventilator, and cut hospital stays.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
lactoferrin (a dietary supplement)
What this could lead to
If it works, this could point toward a simple, low-cost way to prevent a serious lung infection in premature babies on ventilators.
What could go wrong
This is a small, completed trial with only 50 babies, so results may not apply to all newborns. Lactoferrin might not reduce pneumonia risk and could cause digestive issues like vomiting or diarrhea.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for VENTILATOR ASSOCIATED PNEUMONIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Neonatal Intensive Care Unit, Tanta University Children's Hospital
Tanta, Egypt